Insight Molecular Diagnostics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Insight Molecular Diagnostics Inc. (IMDX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-60.66-27.78-72.90-64.10-29.93
Depreciation & Amortization1.561.685.224.210.39
Deferred Income Tax0.000.000.00-9.260.00
Stock Based Compensation1.912.8910.046.845.07
Change in Working Capital-1.32-3.97-1.940.151.98
Change in Accounts Receivable-1.130.11-0.58-1.23-0.18
Change in Inventory-0.410.000.000.000.00
Change in Accounts Payable0.97-4.760.30-1.350.85
Change in Other Working Capital-0.750.68-1.662.731.32
Other Operating Activities-4.28-5.76-31.0216.86-5.26
Net Cash from Operating Activities-20.71-23.33-45.57-35.94-25.98
Investing Activities
Capital Expenditures-0.52-0.28-4.34-2.25-1.23
Acquisitions0.000.000.00-11.71-6.51
Purchases of Investments0.000.370.000.00-4.00
Sales/Maturities of Investments0.000.370.000.000.00
Other Investing Activities0.00-1.370.000.00-0.01
Net Cash from Investing Activities-0.51-0.93-4.34-13.96-11.75
Financing Activities
Debt Repayment-0.20-0.12-1.43-1.530.00
Common Stock Issued27.8113.8532.8483.2022.25
Common Stock Repurchased-5.39-1.120.00-0.24-0.01
Other Financing Activities-1.80-0.43-0.48-3.07-0.13
Net Cash from Financing Activities20.4312.1935.8178.3622.80
Summary
Net Change in Cash-0.80-12.07-14.1028.46-14.93
Cash at Beginning of Period11.1323.2037.318.840.00
Cash at End of Period10.3411.1323.2037.310.00
Free Cash Flow-21.23-23.61-49.91-38.19-27.21
Supplemental Disclosures
Interest Paid0.040.010.020.110.21